Abvc Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.58

+0.01 (+0.64%)

As of Jun 30, 10:42 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +1,463.3% upside

Low Target $17.28

Average Target $24.70

High Target $43.03

Current Price $1.58

Current
$1.58

Target
$24.70

$17.28 $24.70 avg $43.03

Scenario Analysis

Bear Case

$17.28

993.7%

Low target

Base Case

$24.70

+1,463.3%

Avg target

Bull Case

$43.03

+2,623.4%

High target

Risk/Reward

2.6x

Favorable

Price in Context

52-Week High

$5.48

-71.2% from high

52-Week Low

$0.88

+79.5% from low

Target vs 52W High

$24.70

+350.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%